References
- Bentall, R.P. & Morrison, A.P. (2002). More harm than good: The case against using anti-psychotic drugs to prevent severe mental illness. Journal of Mental Health, 11, 351— 356.
- Cornblatt, B., Lencz, T., Correll, C., Author, A. & Smith, C. (2002). Treating the prodrome: naturalistic findings from the RAP program. Acta Psychiatrica Scandinavica, 106, 44.
- McGlashan, T.H. (2001). Psychosis treatment prior to psychosis onset: Ethical issues. Schi-zophrenia Research, 51, 47–54.
- McGorry, P.D., Yung, A.R., Phillips, Li., Yuen, H.P., Francey, S., Cosgrave, E.M., Bravin, J., Adlard, S., MacDonald, T., Blair, A. & Jackson, H. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59, 921 — 928.
- van Os, J., Hanssen, M., Bijl, R.V. & Vollebergh, W. (2001). Prevalence of psychotic disorder and community level of psychotic symptoms: An urban-rural comparison. Archives of Gen-eral Psychiatry, 58, 663 — 668.
- Yung, A.R., Phillips, Li., Yuen, H.P., Francey, S.M., McFarlane, C.A. & McGorry, P.D. (2003). Psychosis Prediction: 12 month follow up of a high risk ('prodromal') group. Schizo-phrenia Research, 60, 21— 32.